.: Instruction for Authors

Instruction to Authors
?2011 NRITLD,National Research Institute of Tuberculosis and Lung Disease,Iran ISSN: 1735-0344 www.Tanaffosjournal.ir
Aims and scope:
The Tanaffos journal,a scientific and research peer reviewed journal,seeks to publish original papers,selected review articles,case reports and other articles of special interest related to the field of respiratory disease,thoracic surgery,intensive care and tuberculosis. The journal is an official publication of the National Research Institute of Tuberculosis and Lung Disease (NRITLD) Shahid Beheshti University of Medical Sciences and Health Services,and is published quarterly. The journal seeks to provide its readers with the highest quality materials published through a process of careful peer reviews and editorial comments. All papers are published in English. The editor requires that authors provide a cover letter in which they state their written assurance of the following:

1) The submitted paper is an original and unpublished work in which the listed authors have all made important contributions.

2) The authors have not submitted the same material or portions thereof for consideration of publication in any other journal for which a decision regarding publication is pending,and no such additional submission will be made before completion of the review process by Tanaffos Journal.

3) The authors must further guarantee that once their material has been accepted for publication by the Journal,they will not make submission of the same material or portions thereof to another journal before publication in Tanaffos Journal. After receiving the manuscript,it would be evaluated and reviewed by two or three reviewers. The final decision to accept manuscripts rests with the Editorial Committee of the Tanaffos Journal. Acceptance of manuscripts for publication depends on their quality,originality,clarity,and relevance to the journals scope. Rejected manuscripts will be held for a limited period of time and then expired.

Manuscript submission

Authors are encouraged to submit their English manuscripts by standard mail or fax. Email submissions are acceptable as well. For further information please visit our website or e-mail the editorial office. The original and two copies of the manuscript including the text,tables and figures along with an electronic file are required. The electronic file must be submitted on a 3.5 inch diskette or CD,labeled with the name of the file,software,and release version.
Our Address:
TANAFFOS JOURNAL Shaheed Bahonar Ave,Darabad TEHRAN 19569,P.O: 19575/154,IRAN- Contact Person: Makan Sadr M.D. Phone: +98-21-26109848 Fax: +98-21-26109848 E-mail address: tanaffosjournal @ gmail.com Website: www. tanaffosjournal.ir
Manuscript preparation:
To avoid unnecessary delays,authors should adhere strictly to the following instructions. Language: You may send your manuscript in English. Typing: All parts of manuscripts must be typed double-spaced in 10 or 12 print typeface,with margins of 2.5cm. Arrange the manuscript with the following components and begin each one on a new page: 1) Title page 2) Abstract and Keywords 3) Body of paper 4) References 5) Acknowledgements 6) Figure legends 7) Tables. Pages should be numbered consecutively.
Length:
There is no limitation in length of the articles submitted in Tanaffos journal for publishing.

General arrangement of papers:
Title: (title page) The title page should contain the following information: 1) The full title of the manuscript,not to exceed 120 characters. No abbreviations are acceptable in the full title. If the work involves the use of an experimental model,the animal species involved must be included in the title. 2) The full names of all authors. Authors should be limited to those individuals contributed in an important manner to the study design,data collection and analysis,or writing of the paper. 3) The department and institution where the work has been performed,as well as the affiliations of the individual authors. 4) Grand support,indicating the source of any financial support for the study. 5) Name and address of the author to whom communication regarding the manuscript should be directed (The author who is responsible for correspondence) including an e-mail address. 6) A shortened version of the title that is 40 characters or less to be used as a running title. Abbreviations: When using abbreviations,write the full name of the abbreviated item followed by the abbreviation in parentheses at the point of first mention of the abbreviation within the body of the manuscript: e.g.,"bronchoalveolar lavage (BAL)". Do not use abbreviations in the abstract or title of the manuscript. Abbreviations may be used in figures and tables,but such abbreviations must be explained in the figure legend or a foot note to the table. When mentioning products such as medicines or equipments,use the generic name,followed by trade name,manufacture (er) name and location: The patient was treated with bilevel nasal positive pressure (BiPAp; Respironics lnc; Murrysville,PA)
Original articles: Observational and experimental articles should conform to the usual structure of abstract,introduction,materials and methods,results,discussion,acknowledgements,references,tables and legends for figures. Subhead in case reports might include: Introduction,Case report,Discussion and Conclusion.
Abstract: Each article should be preceded by an abstract except Review Articles. The abstract must be limited to 250 words. Using abbreviations and footnotes in the body of the abstract must be avoided and references should not be cited here. An abstract includes a brief description of the background,materials and methods,results and conclusion of the study in the form of a structured abstract. Three to ten keywords or short phrases that reflect the content of the manuscript should be provided by the author(s) together with the abstract for indexing. They should be placed in alphabetical order and when possible,adjusted to the medical subject headings of Index Medicus. ( MeSH).
Introduction: This should contain a description of the problem under investigation,reasons for doing the work and a brief survey of the existing literature on the subject. Materials and Methods: Sufficient information must be included to permit repetition of experimental work. Correct chemical names should be given and strains of organisms should be specified. Suppliers of materials need only be mentioned if this may affect the results. Use System International (SI) units and symbols. Results: This section should describe concisely data and findings of research and the rationale of the investigation and its outcomes. The use of tables and figures to illustrate the same results will only rarely be allowed. Tables and figures should be selected to illustrate specific points. Do not tabulate or illustrate points that can be adequately and concisely described in the text. Discussion: This should not simply recapitulate the results. The presentation of results should be separated from a discussion of their significance. It should relate results to previous work and interpret them. Include within the body of the text a description of the ethical guidelines that were followed for human and animal studies. If appropriate,provide citation of institutional review by human or animal research committees. Also describe any hazardous procedures or chemicals involved in the studies and what precautions were taken to avoid injury to subjects or investigators. Within the Methods section,provide a brief but complete description of the statistical methods used including which tests were done for analysis of which variables. Medicines,medication or other materials should be listed as generic items. If brand names are used,they should be placed after the generic name in parenthesis with manufacturers name,city,and State or country. Restrict all comments and discussion to the Discussion section. * Randomized controlled trials should include patients informed consent form and the bioethics committee approval of the corresponding university.
Acknowledgements: This part should include a statement thanking those who assisted substantially with work relevant to the study. Besides personal acknowledgements,sources of financial support should be mentioned in this section,if required. References: Cite references in text in order of appearance using Arabic numerals in parentheses for citations. Place the reference list at the end of the final text page. References should be listed in text citation number order and must be double-spaced. List all authors when six or fewer,when seven or more,list the first six and add "et al". Manuscripts accepted but not yet published can also be included in the references; designate the journal followed by �in press" (in parenthesis). References to unpublished material,such as personal communications and unpublished data,must be placed within the text and not cited in the References section. Personal communication and unpublished data must include the individuals name,location and month and year of communication as appropriate. Use Index Medicus abbreviations for journals that are indexed; if a journal is not indexed,use full name. Following are examples of the most common formats: Standard Journal article: Nakano M,Hasegawa H,Takada T,Ito S,Muramatsu Y,Satoh M,et al. Pulmonary diffusion capacity in patients with systemic lupus erythematosus. Respirology 2002; 7 (1): 45- 9. Organization as author: The Cardiac Society of Australia and New Zealand. Clinical exercise stress testing. Safety and performance guidelines. Med J Aust 1996; 164:282-4. Type of article indicated as needed: Enzensberger W,Fischer PA. Metronome in Parkinson�s disease [letter]. Lancet 1996;347:1337. Books and other monographs: Philips SJ,Whisnant JP. Hypertension and stroke. In: Laragh JH,Brenner BM,editors. Hypertension: pathophysiology,diagnosis,and management. 2nd ed. New York: Raven Press; 1995.p.465-78. Conference paper: Bengtsson S,. Solheim BG. Enforcement of data collection,privacy and security in medical informatics. In: Lun KC,Degoulet P,Piemme Te,et al,editors. MEDINFO 92. Proceedings of the 7 th World Congress on Medical Informatics; 1992 sep 6-10; Geneva,Switzerland. Amsterdam: North-Holland; 1992.p.1561-5 Journal article in electronic format: Morse SS. Factors in the emergence of infectious diseases. Emerg Infect Dis [serial online] 1995 Jan-Mar [cited 1996 Jun 5]; 1(1):[24 screen]. Available from: URL:http://www.cdc. gov /ncidod /EID/eid.htm Monograph in electronic format: CDI,clinical dermatology illustrated [monograph on CD-ROM]. Reeves JRT,Maibach H. CMEA Multimedia Group,producers. 2 nd ed. Version 2.0. San Diego: CMEA; 1995. Tables: Each table should be typewritten with double spacing on a separate page and numbered in order of citation in the text with Arabic numerals. Each table should have a concise heading that makes it comprehensible without reference to the text of the article. Explain any nonstandard abbreviations in a footnote to the table. Figures: Radiographs,CT Scans,ECGs and any other figures must be submitted in quadruplicate in a format suitable for direct reproduction in the journal. Do not send artwork,slides,etc. Appropriate formats include glossy photographs,high- resolution (300 dpi or greater) laser printer output or original artwork. Each figure should be identified on the back by the first authors name,figure number,title of manuscript and correct orientation (i.e. top). Complete anonymity of patients is recommended. Please mask the eye region in photographs of patients. Reprints: Reprints will be provided free of charge. Revision: papers may be returned to authors for modification of the scientific content and / or for shortening and language corrections recommended by reviewers. Revised versions must be submitted to the editor and must be accompanied by a copy of the original version and by a latter listing the changes that have been made. The revised manuscript will be sent to the reviewers again to see if their opinions have been applied.
Proofs:
proofs will be sent to the corresponding author to be checked for only typographical errors and other essential small changes. Major alterations to the text can not be accepted at this stage. Proofs must be returned to the Editor within 3 days of receipt. Copyright: This agreement is made with the Tanaffos Journal. The agreement is for the Article submitted by you ("Author") for publication in the Tanaffos Journal. To enable publishing the Article in the Journal,the ownership of copyright must be established. The author should read and complete the form and return one copy to the journal office. There are explanatory notes to this Agreement,which also form a part of the agreement. In consideration of publication of the article in the Journal,I hereby warrant and undertake a) That this article is an original work has not been published before and is not being considered for publication,elsewhere. b) That I have obtained permission from the copyright holder to reproduce in the Article (print,�) c) That this article contains no violation of any existing copyright or other third party right. d) That I will indemnify and keep indemnified the Editors of the Tanaffos Journal against all claims and expenses,arising from any breach of this warranty. e) That in the case of a multi-authored Article I have obtained copyright assignment from all co-authors. I hereby assign to Tanaffos Journal copyright for the full period of copyright and all renewals,extensions,revisions and revivals together with all rights of action throughout the world in any form and in any language.